Physician profile

Clay E Jones

Optometrist · Indianapolis, IN

NPI 1114983558

$497.51

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$24.76

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $172.08 2020-2023
Glaukos Corporation $108.66 2019
Alcon Vision LLC $62.56 2019-2022
Johnson & Johnson Vision Care, INC. $50.89 2019-2021
Abbvie INC. $32.64 2022
Bausch & Lomb Americas INC. $24.94 2022
Aerie Pharmaceuticals, INC. $24.27 2021
Bausch & Lomb, A Division of Bausch Health US, LLC $21.47 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Clay E Jones

$497.51

in general payments reported 2019-2025

Years
2019-2023
Top company
Novartis Pharmaceuticals Corporation

https://glasscript.com/doctor/394891/clay-e-jones

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.